JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

The Journal of Thoracic and Cardiovascular Surgery, Vol 95, 883-887, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? The Lung Cancer Study Group


This study is based on a retrospective analysis of 163 patients with stage III non-small cell lung cancer randomized to one of three Lung Cancer Study Group postoperative resection-adjuvant treatment protocols. All patients underwent rigorous surgical/pathologic staging including required removal and examination of bronchopulmonary, hilar, subcarinal, and paratracheal lymph nodes. Patients were grouped as follows: group I, only subcarinal nodes diseased (N = 40); group II, only high paratracheal nodes diseases (N = 32); group III, only mid- mediastinal nodes diseased (N = 48); and group IV, subcarinal nodes plus nodes from any other site diseased (N = 43). Patient deaths and tumor recurrences were recorded. The death rate was highest for patients with metastases to subcarinal nodes plus nodes in another site (group IV). Pairwise comparisons of the survival rates of patients in each group disclosed a significant difference between group III and IV (p less than 0.02). In view of this observation, the Lung Cancer Study Group recommends that all patients have rigorous mediastinal lymph node staging done at the time of pulmonary resection to establish prognosis and criteria for study of adjuvant treatment interventions.


This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
M. F. Ismail
Sentinel node sampling in stage I non-small cell lung cancer
Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 948 - 949.
[Full Text] [PDF]

Home page
 ChestHome page
L. A. Robinson, J. C. Ruckdeschel, H. Wagner Jr, and C. W. Stevens
Treatment of Non-small Cell Lung Cancer-Stage IIIA: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 243S - 265S.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
R. Rami-Porta, M. Mateu-Navarro, J. Freixinet, M. de la Torre, A. Jose Torres-Garcia, Y.-W. Pun, A. Canto Armengod, and on behalf of the Bronchogenic Carcinoma Cooperativ
Type of resection and prognosis in lung cancer. Experience of a multicentre study
Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 622 - 628.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
C. Pottgen, W. Eberhardt, S. Bildat, G. Stuben, G. Stamatis, L. Hillejan, S. Sohrab, H. Teschler, S. Seeber, H. Sack, et al.
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial
Ann. Onc., March 1, 2002; 13(3): 403 - 411.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. Andre, D. Grunenwald, J.-P. Pignon, A. Dujon, J. L. Pujol, P. Y. Brichon, L. Brouchet, E. Quoix, V. Westeel, and T. Le Chevalier
Survival of Patients With Resected N2 Non-Small-Cell Lung Cancer: Evidence for a Subclassification and Implications
J. Clin. Oncol., August 16, 2000; 18(16): 2981 - 2989.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. J. Liptay, G. A. Masters, D. J. Winchester, B. L. Edelman, B. J. Garrido, T. R. Hirschtritt, R. M. Perlman, and W. A. Fry
Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer
Ann. Thorac. Surg., August 1, 2000; 70(2): 384 - 389.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka
Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple Stations
Chest, July 1, 2000; 118(1): 123 - 128.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka
PROGNOSIS OF COMPLETELY RESECTED pN2 NON-SMALL CELL LUNG CARCINOMAS: WHAT IS THE SIGNIFICANT NODE THAT AFFECTS SURVIVAL?
J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 270 - 275.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Asamura, H. Nakayama, H. Kondo, R. Tsuchiya, and T. Naruke
LOBE-SPECIFIC EXTENT OF SYSTEMATIC LYMPH NODE DISSECTION FOR NON-SMALL CELL LUNG CARCINOMAS ACCORDING TO A RETROSPECTIVE STUDY OF METASTASIS AND PROGNOSIS
J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1102 - 1111.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. G. Little, A. DeHoyos, D. M. Kirgan, T. R. Arcomano, and K. D. Murray
INTRAOPERATIVE LYMPHATIC MAPPING FOR NON-SMALL CELL LUNG CANCER: THE SENTINEL NODE TECHNIQUE
J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 220 - 224.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. J. M. Chan, MB, U. Pastorino, MD, and P. Goldstraw, FRCS
SYSTEMATIC NODAL DISSECTION IN THE INTRATHORACIC STAGING OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 246 - 251.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. F. Vansteenkiste, P. R. De Leyn, G. J. Deneffe, G. Stalpaert, K. L. Nackaerts, T. E. Lerut, and M. G. Demedts
Survival and Prognostic Factors in Resected N2 Non-Small Cell Lung Cancer: A Study of 140 Cases
Ann. Thorac. Surg., May 1, 1997; 63(5): 1441 - 1450.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. Takizawa, M. Terashima, T. Koike, H. Akamatsu, Y. Kurita, and A. Yokoyama
MEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER
J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 248 - 252.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. J. Mathisen, J. C. Wain, C. Wright, N. Choi, R. Carey, A. Hilgenberg, M. Grossbard, T. Lynch, and H. Grillo
ASSESSMENT OF PREOPERATIVE ACCELERATED RADIOTHERAPY AND CHEMOTHERAPY IN STAGE IIIA (N2) NON-SMALL-CELL LUNG CANCER
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 123 - 133.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Al-Kattan and P. Goldstraw
COMPLETION PNEUMONECTOMY: INDICATIONS AND OUTCOME
J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1125 - 1129.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
J. R. Izbicki, B. Passlick, O. Karg, C. Bloechle, K. Pantel, W. T. Knoefel, and O. Thetter
Impact of Radical Systematic Mediastinal Lymphadenectomy on Tumor Staging in Lung Cancer
Ann. Thorac. Surg., January 1, 1995; 59(1): 209 - 214.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The American Association for Thoracic Surgery.